Literature DB >> 8719783

Nitric oxide synthase in human placenta and umbilical cord from normal, intrauterine growth-retarded and pre-eclamptic pregnancies.

R A Rutherford1, A McCarthy, M H Sullivan, M G Elder, J M Polak, J Wharton.   

Abstract

1. It has been suggested that a deficiency of nitric oxide (NO) may explain many of the pathophysiological features of pre-eclampsia (PE) and intra-uterine (foetal) growth retardation (IUGR). To elucidate further the role of NO in the pathophysiology of pregnancy we have determined the relative amount and activity of NO synthase (NOS) in first trimester and normal-term placental tissues, as well as in the placenta and umbilical cord in pregnancies complicated by PE and IUGR, using NG-nitro-L-[2,3,4,5(-3)H]-arginine ([3H]-L-NOARG) binding, quantitative in vitro autoradiography, [3H]-arginine to [3H]-citrulline conversion and Western blotting. 2. Specific, high affinity (KD = 38 nM) [3H]-L-NOARG binding was demonstrated in the villous trophoblast of normal-term placentae. Binding was calcium-independent, stereoselective and exhibited a rank order of inhibition by NOS inhibitors and substrate (L-NOARG > or = L-NMMA > or = 7-NI > L-NAME > L-Arg > or = L-NIO > ADMA). 3. [3H]-L-NOARG binding density and NOS activity were both significantly greater in placental tissues from first trimester and PE or IUGR complicated pregnancies compared to normal-term placentae. 4. Western blotting, using an endothelial NOS peptide antiserum, demonstrated a approximately 140 KDa protein band in placental extracts and indicated that the amount of immunoreactive material was significantly greater in first trimester compared to normal-term placentae. 5. Specific [3H]-L-NOARG binding was also localized to the endothelial lining of umbilical arteries and veins, binding density being greater in the artery than the vein. [3H]-L-NOARG binding to the umbilical artery endothelium was significantly lower in PE and IUGR complicated pregnancies compared to normal-term controls. 6. The role of trophoblast-derived NO in human placental pathophysiology remains to be established, but differences in the amount of placental [3H]-L-NOARG binding, NOS activity and immunoreactive material indicate that expression of NOS in the villous trophoblast falls during pregnancy. Conversely, the apparent reduction in NOS in the umbilical artery endothelium in PE and IUGR complicated pregnancies may be indicative of endothelial dysfunction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8719783      PMCID: PMC1909176          DOI: 10.1111/j.1476-5381.1995.tb15111.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  58 in total

1.  Regulation of endothelial nitric oxide synthase mRNA, protein, and activity during cell growth.

Authors:  J F Arnal; J Yamin; S Dockery; D G Harrison
Journal:  Am J Physiol       Date:  1994-11

2.  Selective inhibition of the inducible nitric oxide synthase by aminoguanidine.

Authors:  T P Misko; W M Moore; T P Kasten; G A Nickols; J A Corbett; R G Tilton; M L McDaniel; J R Williamson; M G Currie
Journal:  Eur J Pharmacol       Date:  1993-03-16       Impact factor: 4.432

3.  Abnormal endothelial cell function of resistance arteries from women with preeclampsia.

Authors:  A L McCarthy; R G Woolfson; S K Raju; L Poston
Journal:  Am J Obstet Gynecol       Date:  1993-04       Impact factor: 8.661

4.  Neurohistochemical evidence supporting an absence of adrenergic and cholinergic innervation in the human placenta and umbilical cord.

Authors:  F D Reilly; P T Russell
Journal:  Anat Rec       Date:  1977-07

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia.

Authors:  S A Fickling; D Williams; P Vallance; S S Nussey; G S Whitley
Journal:  Lancet       Date:  1993-07-24       Impact factor: 79.321

7.  Pre-eclampsia: more than pregnancy-induced hypertension.

Authors:  J M Roberts; C W Redman
Journal:  Lancet       Date:  1993-06-05       Impact factor: 79.321

8.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

9.  Some statistical methods useful in circulation research.

Authors:  S Wallenstein; C L Zucker; J L Fleiss
Journal:  Circ Res       Date:  1980-07       Impact factor: 17.367

10.  Characterization of the binding of [3H]-L-NG-nitro-arginine in rat brain.

Authors:  A D Michel; R K Phul; T L Stewart; P P Humphrey
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

View more
  9 in total

Review 1.  The feto-placental endothelium in pregnancy pathologies.

Authors:  Christian Wadsack; Gernot Desoye; Ursula Hiden
Journal:  Wien Med Wochenschr       Date:  2012-05

2.  Lack of beneficial effects on the NO-donor, molsidomine, in the L-NAME-induced pre-eclamptic syndrome in pregnant rats.

Authors:  C Richer; H Boulanger; S Es-Slami; J F Giudicelli
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

3.  Trophoblast- and vascular smooth muscle cell-derived MMP-12 mediates elastolysis during uterine spiral artery remodeling.

Authors:  Lynda K Harris; Samantha D Smith; Rosemary J Keogh; Rebecca L Jones; Philip N Baker; Martin Knöfler; Judith E Cartwright; Guy St J Whitley; John D Aplin
Journal:  Am J Pathol       Date:  2010-08-27       Impact factor: 4.307

Review 4.  Role of nitric oxide in placental vascular development and function.

Authors:  B J Krause; M A Hanson; P Casanello
Journal:  Placenta       Date:  2011-07-27       Impact factor: 3.481

5.  Dysregulated flow-mediated vasodilatation in the human placenta in fetal growth restriction.

Authors:  Sarah Jones; Helen Bischof; Ingrid Lang; Gernot Desoye; Sue L Greenwood; Edward D Johnstone; Mark Wareing; Colin P Sibley; Paul Brownbill
Journal:  J Physiol       Date:  2015-06-08       Impact factor: 5.182

6.  VEGF and eNOS expression in umbilical cord from pregnancy complicated by hypertensive disorder with different severity.

Authors:  K Bhavina; J Radhika; S Sundara Pandian
Journal:  Biomed Res Int       Date:  2014-05-14       Impact factor: 3.411

7.  Association of pregnancy-associated plasma protein A and vascular endothelial growth factor with pregnancy-induced hypertension.

Authors:  Zhengzheng Zhang; Hao Xu; Xiao Liu; Pan Li; Wensheng Du; Qiuyu Han
Journal:  Exp Ther Med       Date:  2019-07-02       Impact factor: 2.447

Review 8.  Possible potentials of curcumin for pregnancies complicated by intra-uterine growth restriction: role of inflammation, angiogenesis, and oxidative stress.

Authors:  Mahsa Naemi; Zahra Farahani; Amir Hossein Norooznezhad; Reza Khodarahmi; Sedigheh Hantoushzadeh; Roghaye Ahangari; Mamak Shariat
Journal:  Heliyon       Date:  2021-09-20

9.  Low-Dose Tacrolimus Promotes the Migration and Invasion and Nitric Oxide Production in the Human-Derived First Trimester Extravillous Trophoblast Cells In Vitro.

Authors:  Ahmad J H Albaghdadi; Kassandra Coyle; Frederick W K Kan
Journal:  Int J Mol Sci       Date:  2022-07-29       Impact factor: 6.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.